G-CSF Use Following Introduction of Biosimilars Among Adults With Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Trends in Use of Granulocyte Colony-Stimulating Factor Following Introduction of Biosimilars Among Adults With Cancer and Commercial or Medicare Insurance From 2014 to 2019
JAMA Netw Open 2021 Nov 01;[EPub Ahead of Print], CY Wang, CD Heldermon, SM Vouri, H Park, SE Wheeler, BH Ramnaraign, NH Dang, JD BrownFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.